Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.

International journal of molecular medicine - 1 Aug 2002

Sakai Takahisa, Shiraki Katsuya, Inoue Hidekazu, Okano Hiroshi, Deguchi Masatoshi, Sugimoto Kazushi, Ohmori Shigeru, Murata Kazumoto, Nakano Takeshi

Abstract excerpt

Infection with Hepatitis B virus (HBV) genotype C predominates in Japan. We analyzed the efficacy of interferon (IFN) alpha or beta in the treatment of chronic hepatitis B patients with HBV genotype C and the clinical predictors for therapeutic response. Forty-three genotype C-infected, chronic hepatitis B e antigen (HBeAg)-positive patients (32 men and 11 women with a mean age of 35.6+/-10.1 years) who had been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis B Antibodies

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Interferon-alpha

Share to Interferon-beta

Share to Life Tables

Source

Identifiers

PMID: 12119559

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.PMID 12119559Read ↗

Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan.Semantic proximity Read ↗

Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.Semantic proximity Read ↗

Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.Semantic proximity Read ↗

Efficacy of short-term interferon therapy for patients infected with hepatitis C virus genotype 2a.Semantic proximity Read ↗

Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan.Semantic proximity Read ↗

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.Semantic proximity Read ↗

Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant.Semantic proximity Read ↗

Predictive factors of a response to interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer.Semantic proximity Read ↗

Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis.Semantic proximity Read ↗

Predictive factors in the response to interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.